Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC

Clinical trial NCT04322578 · UNKNOWN

Trial details

NCT number: NCT04322578
Sponsor: Hunan Province Tumor Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2020-03-24
Primary completion: 2025-03-24
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.